Ovalbumin (OVA) is a member of the serpin superfamily and the predominant glycoprotein found in egg whites. It is a commonly used antigen for immunization and biochemical studies and is an established model allergen for airway hyper-responsiveness.This mRNA is capped using CleanCap, TriLink"s proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA. TriLink offers both unmodified and 5-methoxyuridine modified OVA mRNA. Exogenous unmodified mRNA activates the innate immune system and production of cytokines, which will influence the overall induced immune response. mRNA modified with 5-methoxyuridine reduces this effect.
Catalog No | L-7210 |
---|---|
Purity | Passes Agarose Gel Mobility |
Length | 1437 nucleotides |
Base Composition | Fully substituted with 5-Methoxy-U |
Concentration | 1.0 mg/mL |
Buffer | 1 mM Sodium Citrate pH 6.4 |
Conversion Factor | 40 µg/OD260 |
Recommended Storage | At or below -40°C |
Application | Vaccine Development |
Other Name(s) | CleanCap®Ovalbumin mRNA (5-methoxyuridine) |
CleanCap For Research Use Only. Not for use in humans. Not for use in diagnostic or therapeutic purposes. For additional licensing restrictions, please see the license agreement at trilinkbiotech.com/cleancap-research-license. Patent or patent pending,see trilinkbiotech.com/legal-notices.
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser"s sole responsibility.
Solulink位于美国加州圣地亚哥市生物公司云集的Sorrento Valley地区,成立于2003年。Solulink公司致力于发展高性能的生物分子偶联产品。可用于任何含有氨基的生物分子标记的ChromaLink™抗体标记试剂盒(ChromaLink™ Antibody Labeling Kit)和One-Shot(单标记)系列试剂盒的成功开发代表着他们始终如一地提供创新产品的承诺,以满足客户不断变化的需求。Solulink是第一 家提供包括纯化的完整抗体标记试剂盒的公司,并且正在开发更多令人振奋的新结合试剂盒。Solulink公司的产品包括:生物素&地高辛标记、磁 珠和琼脂糖标记、抗体标记、抗体-Oligo标记、生物素和链亲合素、肽连接与合成、交联产品以及其他标记试剂等。